Cart
0

Hemodialysis Market by Type (Conventional [3 times per week], Daily [6 days a week], and Nocturnal [3-6 nights per week]), Product & Service (Equipment, Consumable, Drug, and Service), and End User (In-center dialysis and Home dialysis) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report
LI_184660
Pages: 240
Jul 2018 | 671 Views
 
Author's : Amrita Srivastava & Pallavi Jaiswal
Tables: 112
Charts: 48
 

Global Hemodialysis Market Overview:

The global hemodialysis market size was valued at $71,501 million in 2017 and is expected to reach $99,747 million by 2025, growing at a CAGR of 4.2% from 2018 to 2025. For patients suffering from kidney failure and other renal impairments, hemodialysis functions similar to an artificial kidney. Hemodialysis filters out toxins and removes excess fluid from blood. This process of filtration and removal is performed by the hemodialyzer.

Get more information on this report : Request Sample Pages

The global hemodialysis market is driven by increase in incidence of hypertension and diabetes. Moreover, rise in number of end stage renal disorder (ESRD) patients and shortage in availability of kidneys for transplants are the key factors that augment the growth of the market. However, numerous product recalls and risks and complications associated with dialysis are some of the factors that hinder the market growth. On the contrary, the presence of untapped markets in the emerging nations is expected to provide new opportunities for the key players.

The hemodialysis market is segmented on the basis of type, product and service, end user, and region. On the basis of type, it is categorized into conventional (3 times per week), daily (6 days a week), and nocturnal (3-6 nights per week). According to product and service, it is categorized into equipment, consumable, drug, and service.

Get more information on this report : Request Sample Pages

By end user, hemodialysis industry is divided into in-center dialysis and home dialysis. Region-wise, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Spain, Italy, and Rest of Europe), Asia-Pacific (Japan, China, Singapore, India, South Korea, and Rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and Rest of LAMEA).

The service segment dominated the global hemodialysis market in 2017, owing to the frequency of use by patients, which was thrice a week.


Get more information on this report : Request Sample Pages

Rise in focus of vendors on the emerging markets, such as Asia-Pacific and LAMEA, is expected to boost the market growth. The Asia-Pacific region is projected to witness significant growth in future, owing to increase in R&D investment and surge in disease diagnosis awareness. Furthermore, this region presents remarkable opportunities forĀ  venture capitalists and investors, because the developed markets are comparatively saturated.

by geography
Get more information on this report : Request Sample Pages

The report provides an extensive competitive analysis and profiles of the key market players, such as Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International, Inc., Cantel Medical Corp., DaVita, Inc., Diaverum, Fresenius Medical Care AG & Co. KGaA, Nikkiso Co., Ltd., Nipro Corporation, and NxStage Medical, Inc. The other players in the value chain (not included in the report) include Gambro, Satellite Healthcare, Inc., and MEDIVATORS, Inc.

Key Benefits

  • This report entails a detailed quantitative analysis of the current market trends from 2017 to 2025 to identify the prevailing opportunities along with strategic assessment of the global hemodialysis market.
  • Hemodialysis market size and estimations are based on comprehensive analysis of the applications and developments in the industry.
  • A qualitative analysis based on innovative products and devices facilitate the strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the global hemodialysis industry.

Hemodialysis Market Key Segments:

By type

  • Conventional (3 times per week)
  • Daily (6 days a week)
  • Nocturnal (3-6 nights per week)

By product and service

  • Equipment
  • Consumable
  • Drug
  • Service

By end user

  • In-center dialysis
  • Home dialysis

By region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key Benefits for Stakeholders
1.3. Key Market Segments

1.3.1. List of players profiled in the report

1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key Findings of the Study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market Definition and Scope
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Clinical trials
3.4. Market Dynamics

3.4.1. Drivers

3.4.1.1. Increase in funding for improved dialysis products and services
3.4.1.2. Increase in the number of ESRD patients
3.4.1.3. Rise in incidence of diabetes and hypertension
3.4.1.4. Shortage of kidneys for transplantation

3.4.2. Restraints

3.4.2.1. Risks and complications associated with dialysis
3.4.2.2. Product recall

3.4.3. Opportunities

3.4.3.1. Technological advancements leading to better adoption
3.4.3.2. Growth opportunities in emerging economies

3.4.4. Impact Analyses

3.5. Patent analysis (2013-2018)

3.5.1. Patent analysis, by year

Chapter: 4: HEMODIALYSIS MARKET, BY PRODUCTS AND SERVICES

4.1. Overview

4.1.1. Market size and forecast

4.2. Equipment

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by type
4.2.3. Dialysis Machines

4.2.3.1. Market size and forecast

4.2.4. Hemodialysis Water Treatment Systems

4.2.4.1. Market size and forecast

4.2.5. Others hemodialysis equipment

4.2.5.1. Market size and forecast

4.2.6. Market size and forecast, by region
4.2.7. Market analysis, by country

4.3. Consumables

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by type
4.3.3. Dialyzers

4.3.3.1. Market size and forecast

4.3.4. Catheters

4.3.4.1. Market size and forecast

4.3.5. Other hemodialysis consumables

4.3.5.1. Market size and forecast

4.3.6. Market size and forecast, region
4.3.7. Market analysis, by country

4.4. Drugs

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Services

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

Chapter: 5: HEMODIALYSIS MARKET, BY TYPE

5.1. Overview
5.2. Conventional hemodialysis

5.2.1. Market analysis, by country

5.3. Short daily hemodialysis/daily hemodialysis

5.3.1. Market analysis, by country

5.4. Nocturnal hemodialysis

5.4.1. Market analysis, by country

Chapter: 6: HEMODIALYSIS MARKET BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by country

6.2.2.1. U.S.

6.2.2.1.1. U.S. hemodialysis market, by type
6.2.2.1.2. U.S. hemodialysis market, by product and service
6.2.2.1.3. U.S. hemodialysis market, by end user

6.2.2.2. Canada

6.2.2.2.1. Canada hemodialysis market, by type
6.2.2.2.2. Canada hemodialysis market, by product and service
6.2.2.2.3. Canada hemodialysis market, by end user

6.2.2.3. Mexico

6.2.2.3.1. Mexico hemodialysis market, by type
6.2.2.3.2. Mexico hemodialysis market, by product and service
6.2.2.3.3. Mexico hemodialysis market, by end user

6.2.3. North America hemodialysis market, by type
6.2.4. North America hemodialysis market, by product and service
6.2.5. North America hemodialysis market, by end user

6.3. Europe

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by country

6.3.2.1. Germany

6.3.2.1.1. Germany hemodialysis market, by type
6.3.2.1.2. Germany hemodialysis market, by product and service
6.3.2.1.3. Germany hemodialysis market, by end user

6.3.2.2. France

6.3.2.2.1. France hemodialysis market, by type
6.3.2.2.2. France hemodialysis market, by product and service
6.3.2.2.3. France hemodialysis market, by end user

6.3.2.3. UK

6.3.2.3.1. UK hemodialysis market, by type
6.3.2.3.2. UK hemodialysis market, by product and service
6.3.2.3.3. UK hemodialysis market, by end user

6.3.2.4. Italy

6.3.2.4.1. Italy hemodialysis market, by type
6.3.2.4.2. Italy hemodialysis market, by product and service
6.3.2.4.3. Italy hemodialysis market, by end user

6.3.2.5. Spain

6.3.2.5.1. Spain hemodialysis market, by type
6.3.2.5.2. Spain hemodialysis market, by product and service
6.3.2.5.3. Spain hemodialysis market, by end user

6.3.2.6. Rest of Europe

6.3.2.6.1. Rest of Europe hemodialysis market, by type
6.3.2.6.2. Rest of Europe hemodialysis market, by product and service
6.3.2.6.3. Rest of Europe hemodialysis market, by end user

6.3.3. Europe hemodialysis market, by type
6.3.4. Europe hemodialysis market, by product and service
6.3.5. Europe hemodialysis market, by end user

6.4. Asia-Pacific

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by country

6.4.2.1. Japan

6.4.2.1.1. Japan hemodialysis market, by type
6.4.2.1.2. Japan hemodialysis market, by product and service
6.4.2.1.3. Japan hemodialysis market, by end user

6.4.2.2. China

6.4.2.2.1. China hemodialysis market, by type
6.4.2.2.2. China hemodialysis market, by product and service
6.4.2.2.3. China hemodialysis market, by end user

6.4.2.3. India

6.4.2.3.1. India hemodialysis market, by type
6.4.2.3.2. India hemodialysis market, by product and service
6.4.2.3.3. India hemodialysis market, by end user

6.4.2.4. Australia

6.4.2.4.1. Australia hemodialysis market, by type
6.4.2.4.2. Australia hemodialysis market, by product and service
6.4.2.4.3. Australia hemodialysis market, by end user

6.4.2.5. South Korea

6.4.2.5.1. South Korea hemodialysis market, by type
6.4.2.5.2. South Korea hemodialysis market, by product and service
6.4.2.5.3. South Korea hemodialysis market, by end user

6.4.2.6. Rest of Asia-Pacific

6.4.2.6.1. Rest of Asia-Pacific hemodialysis market, by type
6.4.2.6.2. Rest of Asia-Pacific hemodialysis market, by product and service
6.4.2.6.3. Rest of Asia-Pacific hemodialysis market, by end user

6.4.3. Asia-Pacific hemodialysis market, by type
6.4.4. Asia-Pacific hemodialysis market, by product and service
6.4.5. Asia-Pacific hemodialysis market, by end user

6.5. LAMEA

6.5.1. Key market trends, growth factors, and opportunities
6.5.2. Market size and forecast, by country

6.5.2.1. Brazil

6.5.2.1.1. Brazil hemodialysis market, by type
6.5.2.1.2. Brazil hemodialysis market, by product and service
6.5.2.1.3. Brazil hemodialysis market, by end user

6.5.2.2. Saudi Arabia

6.5.2.2.1. Saudi Arabia hemodialysis market, by type
6.5.2.2.2. Saudi Arabia hemodialysis market, by product and service
6.5.2.2.3. Saudi Arabia hemodialysis market, by end user

6.5.2.3. South Africa

6.5.2.3.1. South Africa hemodialysis market, by type
6.5.2.3.2. South Africa hemodialysis market, by product and service
6.5.2.3.3. South Africa hemodialysis market, by end user

6.5.2.4. Rest of LAMEA

6.5.2.4.1. Rest of LAMEA hemodialysis market, by type
6.5.2.4.2. Rest of LAMEA hemodialysis market, by product and service
6.5.2.4.3. Rest of LAMEA hemodialysis market, by end user

6.5.3. LAMEA hemodialysis market, by type
6.5.4. LAMEA hemodialysis market, by product and service
6.5.5. LAMEA hemodialysis market, by end user

Chapter: 7: COMPANY PROFILES

7.1. Asahi Kasei Corporation.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio
7.1.5. Business performance

7.2. B. Braun Melsungen AG

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. Baxter International Inc.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. Cantel Medical Corp.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product Portfolio
7.4.5. Business performance

7.5. DaVita Inc.

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments

7.6. Diaverum.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Product Portfolio
7.6.4. Key strategic moves and developments

7.7. Fresenius Medical Care AG & Co. KGaA

7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product Portfolio
7.7.5. Business performance
7.7.6. Key strategic moves and developments

7.8. Nikkiso Co., Ltd.

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance
7.8.6. Key strategic moves and developments

7.9. Nipro Corporation

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments

7.10. NxStage Medical, Inc.

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segments
7.10.4. Product Portfolio
7.10.5. Business performance
7.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. HEMODIALYSIS MARKET, BY PRODUCTS AND SERVICES, 2017-2025 ($MILLION)
TABLE 02. HEMODIALYSIS EQUIPMENT/DEVICE MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 03. HEMODIALYSIS EQUIPMENT/DEVICE MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 04. GLOBAL HEMODIALYSIS CONSUMABLES MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 05. HEMODIALYSIS CONSUMABLES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 06. HEMODIALYSIS DRUGS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 07. HEMODIALYSIS SERVICES MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 08. GLOBAL HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 09. CONVENTIONAL HEMODIALYSIS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 10. SHORT DAILY/ DAILY HEMODIALYSIS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 11. NOCTURNAL HEMODIALYSIS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 12. HEMODIALYSIS MARKET, BY REGION, 2017-2025 ($MILLION)
TABLE 13. NORTH AMERICA HEMODIALYSIS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 14. U.S. HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 15. U.S. HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 16. U.S. HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 17. CANADA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 18. CANADA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 19. CANADA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 20. MEXICO HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 21. MEXICO HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 22. MEXICO HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 23. NORTH AMERICA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 24. NORTH AMERICA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 25. NORTH AMERICA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 26. EUROPE HEMODIALYSIS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 27. GERMANY HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 28. GERMANY HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 29. GERMANY HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 30. FRANCE HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 31. FRANCE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 32. FRANCE HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 33. UK HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 34. UK HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 35. UK HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 36. ITALY HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 37. ITALY HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 38. ITALY HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 39. SPAIN HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 40. SPAIN HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 41. SPAIN HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 42. REST OF EUROPE HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 43. REST OF EUROPE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 44. REST OF EUROPE HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 45. EUROPE HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 46. EUROPE HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 47. EUROPE HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 48. ASIA-PACIFIC HEMODIALYSIS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 49. JAPAN HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 50. JAPAN HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 51. JAPAN HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 52. CHINA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 53. CHINA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 54. CHINA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 55. INDIA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 56. INDIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 57. INDIA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 58. ITALY HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 59. AUSTRALIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 60. AUSTRALIA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 61. SOUTH KOREA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 62. SOUTH KOREA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 63. SOUTH KOREA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 64. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 65. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 66. REST OF ASIA-PACIFIC HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 67. ASIA-PACIFIC HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 68. ASIA-PACIFIC HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 69. ASIA-PACIFIC HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 70. LAMEA HEMODIALYSIS MARKET, BY COUNTRY, 2017-2025 ($MILLION)
TABLE 71. BRAZIL HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 72. BRAZIL HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 73. BRAZIL HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 74. SAUDI ARABIA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 75. SAUDI ARABIA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 76. SAUDI ARABIA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 77. SOUTH AFRICA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 78. SOUTH AFRICA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 79. SOUTH AFRICA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 80. REST OF LAMEA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 81. REST OF LAMEA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 82. REST OF LAMEA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 83. LAMEA HEMODIALYSIS MARKET, BY TYPE, 2017-2025 ($MILLION)
TABLE 84. LAMEA HEMODIALYSIS MARKET, BY PRODUCT AND SERVICE, 2017-2025 ($MILLION)
TABLE 85. LAMEA HEMODIALYSIS MARKET, BY END USER, 2017-2025 ($MILLION)
TABLE 86. ASAHI KASEI: COMPANY SNAPSHOT
TABLE 87. ASAHI KASEI: OPERATING SEGMENTS
TABLE 88. ASAHI KASEI: PRODUCT PORTFOLIO
TABLE 89. B. BRAUN: COMPANY SNAPSHOT
TABLE 90. B. BRAUN: OPERATING SEGMENTS
TABLE 91. B. BRAUN: PRODUCT PORTFOLIO
TABLE 92. BAXTER: COMPANY SNAPSHOT
TABLE 93. BAXTER: BUSINESS UNITS
TABLE 94. CANTEL MEDICAL: COMPANY SNAPSHOT
TABLE 95. CANTEL MEDICAL: OPERATING SEGMENTS
TABLE 96. CANTEL MEDICAL: PRODUCT PORTFOLIO
TABLE 97. DAVITA: COMPANY SNAPSHOT
TABLE 98. DAVITA: OPERATING SEGMENTS
TABLE 99. DAVITA: PRODUCT PORTFOLIO
TABLE 100. DIAVERUM: COMPANY SNAPSHOT
TABLE 101. DIAVERUM: PRODUCT PORTFOLIO
TABLE 102. FRESENIUS: COMPANY SNAPSHOT
TABLE 103. FRESENIUS: OPERATING SEGMENTS
TABLE 104. FRESENIUS: PRODUCT PORTFOLIO
TABLE 105. NIKKISO : COMPANY SNAPSHOT
TABLE 106. NIKKISO: OPERATING SEGMENTS
TABLE 107. NIKKISO: PRODUCT PORTFOLIO
TABLE 108. NIPRO: COMPANY SNAPSHOT
TABLE 109. NIPRO: OPERATING SEGMENTS
TABLE 110. NXSTAGE: COMPANY SNAPSHOT
TABLE 111. NXSTAGE: OPERATING SEGMENTS
TABLE 112. NXSTAGE: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01. HEMODIALYSIS MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 20152018*
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 20152018* (%)
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 20152018**
FIGURE 06. CLINICAL TRIALS IN HEMODIALYSIS MARKET, BY REGION*
FIGURE 07. CLINICAL TRIALS IN HEMODIALYSIS MARKET, NORTH AMERICA*
FIGURE 08. IMPACT ANALYSES, GLOBAL HEMODIALYSIS MARKET
FIGURE 09. PATENTS REGISTERED/APPROVED IN THE WORLD, 2013-2018
FIGURE 10. PATENTS ANALYSIS BY YEAR, 2013 THROUGH 2017
FIGURE 11. HEMODIALYSIS MACHINES MARKET, 2017- 2025 ($MILLION)
FIGURE 12. HEMODIALYSIS WATER TREATMENT SYSTEMS MARKET, 2017- 2025 ($MILLION)
FIGURE 13. OTHER HEMODIALYSIS EQUIPMENT MARKET 2017-2025 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF HEMODIALYSIS EQUIPMENT/DEVICE MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 15. DIALYZERS MARKET 2017-2025 ($MILLION)
FIGURE 16. CATHETERS MARKET 2017-2025 ($MILLION)
FIGURE 17. OTHER HEMODIALYSIS CONSUMABLES MARKET 2017-2025 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF HEMODIALYSIS CONSUMABLES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF HEMODIALYSIS DRUGS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF HEMODIALYSIS SERVICES MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF CONVENTIONAL HEMODIALYSIS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 22. SHORT DAILY/ DAILY HEMODIALYSIS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 23. NOCTURNAL HEMODIALYSIS MARKET, BY COUNTRY, 2017 & 2025 (%)
FIGURE 24. NET SALES, 2015-2017 ($MILLION)
FIGURE 25. : NET SALES BY SEGMENT, 2017 (%)
FIGURE 26. ASAHI KASEI: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 27. NET SALES, 2015-2017 ($MILLION)
FIGURE 28. B. BRAUN: NET SALES BY DIVISION, 2017 (%)
FIGURE 29. B. BRAUN: NET SALES BY REGION, 2017 (%)
FIGURE 30. NET SALES, 2015-2017 ($MILLION)
FIGURE 31. BAXTER: REVENUE SHARE BY BUSINESS UNIT, 2017 (%)
FIGURE 32. BAXTER: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 33. NET SALES, 2015-2017 ($MILLION)
FIGURE 34. CANTEL MEDICAL: NET SALES BY SEGMENT, 2017 (%)
FIGURE 35. CANTEL MEDICAL: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 36. NET SALES, 2015-2017 ($MILLION)
FIGURE 37. DAVITA: NET SALES BY SEGMENT, 2017 (%)
FIGURE 38. FRESENIUS: NET SALES, 2015-2017 ($MILLION)
FIGURE 39. FRESENIUS: NET SALES BY SEGMENT, 2017 (%)
FIGURE 40. FRESENIUS: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 41. NET SALES, 2015-2017 ($MILLION)
FIGURE 42. NIKKISO: NET SALES BY BUSINESS SEGMENT, 2017 (%)
FIGURE 43. NIKKISO: NET SALES BY REGION, 2017 (%)
FIGURE 44. NET SALES, 2015-2017 ($MILLION)
FIGURE 45. NIPRO: NET SALES BY SEGMENT, 2017 (%)
FIGURE 46. NIPRO: NET SALES BY GEOGRAPHY, 2017 (%)
FIGURE 47. REVENUES, 2015-2017 ($MILLION)
FIGURE 48. NXSTAGE: REVENUES BY SEGMENT, 2017 (%)

 

Hemodialysis is a medical procedure performed extensively on patients with end stage renal disorders (ESRD). This procedure is employed for removal of waste from blood and maintenance of electrolyte balance in the body. The growth of the global hemodialysis market is propelled by rise in incidence of diabetes and hypertension and increase in the number of ESRD patients. Furthermore, technological advancements leading to increase in adoption of hemodialysis are anticipated to boost the market growth during the forecast period.

The use of the hemodialysis procedure is highest in North America, attributed to the technological advancements in patient care and well-established healthcare infrastructure. North America is followed by Europe and Asia-Pacific. In addition, hemodialyzer manufacturing companies and hemodialysis service-providing companies have focused on expanding their presence in the emerging economies, which is anticipated to drive the market growth.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
Hemodialysis Market- Global Opportunity Analysis and Industry Forecast, 2018-2025

  • Online Only
  • $3456 $3111
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $3840 $3456
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5370 $4565
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6450 $5160
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $8995 $6747
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo